Request a copy

Full Text

• Mulvagh SL, DeMaria AN, Feinstein SB, Burns PN, Kaul S, Miller JG, Monaghan M, Porter TR, Shaw LJ, Villanueva FS. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 2000; 13: 331-342 (Pubitemid 30215261)
• Hoffmann R, von Bardeleben S, Kasprzak JD, Borges AC, ten Cate F, Firschke C, Lafitte S, Al-Saadi N, Kuntz-Hehner S, Horstick G, Greis C, Engelhardt M, Vanoverschelde JL, Becher H. Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography: a multicenter comparison of methods. J Am Coll Cardiol 2006; 47: 121-128
• Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2004; 44: 1030-1035 (Pubitemid 39165138)
• Kitzman DW, Goldman ME, Gillam LD, Cohen JL, Aurigemma GP, Gottdiener JS. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 2000; 86: 669-674
• Van Camp G, Droogmans S, Cosyns B. Bio-effects of ultrasound contrast agents in daily clinical practice: fact or fiction? Eur Heart J 2007; 28: 1190-1192
• Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D, Bierig M, Mulvagh SL, Porter TR, Labovitz AJ. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography: a multicenter experience. J Am Coll Cardiol 2009; 53: 32-38
• Wei K. Detection and quantification of coronary stenosis severity with myocardial contrast echocardiography. Prog Cardiovasc Dis 2001; 44: 81-100. (Pubitemid 32896026)
• Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008; 60: 1153-1166
• Blomley M, Claudon M, Cosgrove D. WFUMB safety symposium on ultrasound contrast agents: Clinical applications and safety concerns. Ultrasound Med Biol 2007; 33: 180-186 (Pubitemid 46240590)
• Main ML, Goldman JH, Grayburn PA. Thinking outside the "box"- The ultrasound contrast controversy. J Am Coll Cardiol 2007; 50: 2434-2437
• EMEA. Scientific Discussion. European Medicines Agency 2004, CPMP/0053/01. http://www.emea.europa.eu/humandocs/human/epar/sonovue/sonovue.htm (2004).
• EMEA. http://www.emea.europa.eu/,document reference: Emea/cpmp/212/04 (2004).
• FDA. US Food and Drug Administration. Definity®: vial for (perflutren lipid microsphere) injectable suspension: for intravenous use. Available at: http://www.fda.gov/cder/foi/label/2007/021064 s0071bl.pdf. (2007).
• FDA. United States Food and Drug Administration Center for Drug Evaluation and Research alert for healthcare providers. Available at http://www.fda.gov/cder/drug/infopage/microbubble/default.htm. (2008).
• Szebeni J. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology 2005; 216: 106-121 (Pubitemid 41712000)
• Fisher NG, Christiansen JP, Klibanov A, Taylor RP, Kaul S, Lindner JR. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol 2002; 40: 811-819 (Pubitemid 34925631)
• Linka AZ, Skyba DM, Price RJ, Wei K, Skalak TC, Kaul S. Spontaneous redistribution after reperfusion: A unique property of AIP 201, an ultrasound contrast agent. J Am Coll Cardiol 1998; 32: 1765-1772 (Pubitemid 28545218)
• Dalecki D, Raeman CH, Child SZ, Carstensen EL. A test for cavitation as a mechanism for intestinal hemorrhage in mice exposed to a piezoelectric lithotripter. Ultrasound Med Biol 1996; 22: 493-496 (Pubitemid 26166941)
• Dayton PA, Chomas JE, Lum AFH, Allen JS, Lindner JR, Simon SI, Ferrara KW. Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys J 2001; 80: 1547-1556 (Pubitemid 32182178)
• Miller DL. Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation. Prog Biophys Mol Biol 2007; 93: 314-330
• Miller DL, Quddus J. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol 2000; 26: 661-667 (Pubitemid 30336669)
• Ay T, Havaux X, Van Camp G, Campanelli B, Gisellu G, Pasquet A, Denef JF, Melin JA, Vanoverschelde JL. Destruction of contrast microbubbles by ultrasound: effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation 2001; 104: 461-466 (Pubitemid 32678278)
• Miller DL, Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci USA 2000; 97: 10179-10184 (Pubitemid 30680875)
• Vancraeynest D, Havaux X, Pasquet A, Gerber B, Beauloye C, Rafter P, Bertrand L, Vanoverschelde JL. Myocardial injury induced by ultrasound-targeted microbubble destruction: Evidence for the contribution of myocardial ischemia. Ultrasound Med Biol 2009; 35: 672-679
• Raisinghani A, Wei KS, Crouse L, Villanueva F, Feigenbaum H, Schiller NB, Weiss J, Naqvi TZ, Siegel R, Monaghan M, Goldman JH, DeMaria A. Myocardial contrast echocardiography (MCE) with triggered ultrasound does not cause premature ventricular complexes: evidence from PB127 MCE studies. J Am Soc Echocardiogr 2003; 16: 1037-1042
• van Der Wouw PA, Brauns AC, Bailey SE, Powers JE, Wilde AA. Premature ventricular contractions during triggered imaging with ultrasound contrast. J Am Soc Echocardiogr 2000; 13: 288-294
• Knebel F, Schimke I, Eddicks S, Walde T, Ziebig R, Schattke S, Baumann G, Borges AC. Does contrast echocardiography induce increases in markers of myocardial necrosis, inflammation and oxidative stress suggesting myocardial injury? Cardiovasc Ultrasound 2005; 3: 21.
• Vancraeynest D, Kefer J, Hanet C, Fillee C, Beauloye C, Pasquet A, Gerber BL, Philippe M, Vanoverschelde JL. Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans. Eur Heart J 2007; 28: 1236-1241 (Pubitemid 47343836)
• Gabriel RS, Smyth YM, Menon V, Klein AL, Grimm RA, Thomas JD, Sabik EM. Safety of ultrasound contrast agents in stress echocardiography. Am J Cardiol 2008; 102: 1269-1272
• Wei K, Mulvagh SL, Carson L, Davidoff R, Gabriel R, Grimm RA, Wilson S, Fane L, Herzog CA, Zoghbi WA, Taylor R, Farrar M, Chaudhry FA, Porter TR, Irani W, Lang RM. The safety of definity and optison for ultrasound image enhancement: A retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr 2008; 21: 1202-1206
• Timperley J, Mitchell AR, Thibault H, Mirza IH, Becher H. Safety of contrast dobutamine stress echocardiography: a single center experience. J Am Soc Echocardiogr 2005; 18: 163-167 (Pubitemid 40170045)
• Herzog CA. Incidence of adverse events associated with use of perflutren contrast agents for echocardiography. JAMA 2008; 299: 2023-2025
• Tsutsui JM, Elhendy A, Xie F, O'Leary EL, McGrain AC, Porter TR. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol 2005; 45:1235-1242 (Pubitemid 40523143)
• Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D, Bierig M, Mulvagh SL, Porter TR, Labovitz AJ. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography: a multi-center experience. J Am Coll Cardiol 2009; 53: 32-38
• Szebeni J, Fontana JL, Wassef NM, Mongan PD, Morse DS, Dobbins DE, Stahl GL, Bunger R, Alving CR. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a anti-body. Circulation 1999; 99: 2302-2309
• Stuart RJ, Jr., Ellestad MH. National survey of exercise stress testing facilities. Chest 1980; 77: 94-97 (Pubitemid 10219241)
• Daniel WG, Erbel R, Kasper W, Visser CA, Engberding R, Sutherland GR, Grube E, Hanrath P, Maisch B, Dennig K, Schartl M, Kremer P, Angermann C, Iliceto S, Curtius JM, Mügge A. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation 1991; 83: 817-821
• Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media - gadolinium chelates. Br J Radiol 2006; 79: 368-371 (Pubitemid 43676338)
• Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group. Circulation 1990; 81: 1205-1209
• Pepine CJ, Hill JA, Lambert CR. Diagnostic and therapeutic cardiac catheterization. Baltimore, 1989, Lippincott, Williams: 1066.
• Cosyns B, El Haddad P, Lignian H, Daniels C, Weytjens C, Schoors D, Van Camp G. Contrast harmonic imaging improves the evaluation of left ventricular function in ventilated patients: comparison with transesophageal echocardiography. Eur J Echocardiogr 2004; 5: 118-122 (Pubitemid 38279317)
• Korabluth M, Liang DH, Brown P, Gessford E, Schnittger I. Contrast echocardiography is superior to tissue harmonics for assessment of left ventricular function in mechanically ventilated patients. Am Heart J 2000; 140: 291-296 (Pubitemid 30641593)
• Reilly JP, Tunick PA, Timmermans RJ, Stein B, Rosenzweig BP, Kronzon I. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients. J Am Coll Cardiol 2000; 35: 485-490 (Pubitemid 30125542)
• Yong Y, Wu D, Fernandes V, Kopelen HA, Shimoni S, Nagueh SF, Callahan JD, Bruns DE, Shaw LJ, Quinones MA, Zoghbi WA. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 2002; 89: 711-718 (Pubitemid 34230568)
• Kusnetzky LL, Khalid A, Khumri TM, Moe TG, Jones PG, Main ML. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: Results in 18,671 consecutive studies. J Am Coll Cardiol 2008; 51: 1704-1706
• Main ML, Ryan AC, Davis TE, Albano MP, Kusnetzky LL, Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol 2008; 102: 1742-1746
• Nucifora G, Marsan NA, Siebelink HM, van Werkhoven JM, Schuijf JD, Schalij MJ, Poldermans D, Holman ER, Bax JJ. Safety of contrast-enhanced echocardiography within 24 h after acute myocardial infarction. Eur J Echocardiogr 2008; 9: 816-818
• Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Jr., Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: E1-E211.
• Frances C, Romero A, Grady D. Left ventricular pseudoaneurysm. J Am Coll Cardiol 1998; 32: 557-561
• Uno K, Takenaka K, Asada K, Ebihara A, Sasaki K, Komuro T, Nagai R, Motomura N, Ono M, Takamoto S. Diagnosis of subacute cardiac rupture by contrast echocardiography. J Am Soc Echocardiogr 2006; 19: 1401 e9-1401 e11. (Pubitemid 46053700)
• Garcia-Fernandez MA, Macchioli RO, Moreno PM, Yanguela MM, Thomas JB, Sendon JL, Lopez de Sa E, Abdou YH. Use of contrast echocardiography in the diagnosis of subacute myocardial rupture after myocardial infarction. J Am Soc Echocardiogr 2001; 14: 945-947
• Mansencal N, Nasr IA, Pilliere R, Farcot JC, Joseph T, Lacombe P, Dubourg O. Usefulness of contrast echocardiography for assessment of left ventricular thrombus after acute myocardial infarction. Am J Cardiol 2007; 99: 1667-1670 (Pubitemid 46881146)
• Hayat SA, Senior R. Myocardial contrast echocardiography in ST elevation myocardial infarction: ready for prime time? Eur Heart J 2008; 29: 299-313.
• Jaffe R, Charron T, Puley G, Dick A, Strauss BH. Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 2008; 117: 3152-3156
• Karshafian R, Bevan PD, Williams R, Samac S, Burns PN. Sonoporation by ultrasound-activated microbubble contrast agents: Effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med Biol 2009; 35: 847-860